Previous close | 66.90 |
Open | 66.90 |
Bid | 52.50 |
Ask | 56.80 |
Strike | 125.00 |
Expiry date | 2025-12-19 |
Day's range | 66.90 - 66.90 |
Contract range | N/A |
Volume | |
Open interest | 15 |
Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY) Q1 2024 Earnings Call Transcript May 2, 2024 Alnylam Pharmaceuticals, Inc. beats earnings expectations. Reported EPS is $-0.52272, expectations were $-0.75. ALNY isn’t one of the 30 most popular stocks among hedge funds at the end of the third quarter (see the details here). Operator: Good day and thank you for […]
Alnylam (ALNY) reports better-than-expected first-quarter 2024 results as both earnings and revenues beat estimates, primarily driven by strong Amvuttra sales.
Alnylam Pharmaceuticals ( NASDAQ:ALNY ) First Quarter 2024 Results Key Financial Results Revenue: US$494.3m (up 55...